Back
IDEXX Laboratories Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
55
IDXX
IDEXX Laboratories
Last Price:
$411.78
Seasonality Move:
7.91%
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$53.80
Seasonality Move:
13.2%
Buy
55
IDEXX Laboratories (IDXX)
is a Buy
Is IDEXX Laboratories a Buy, Sell or Hold?
-
The current IDEXX Laboratories [IDXX] share price is $411.49. The Score for IDXX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
IDXX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $53.79. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IDXX Stock Price Chart
What is IDEXX Laboratories's stock price today?
-
The IDEXX Laboratories share price today is $411.49The current trend is relatively stagnant and IDXX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $53.79Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
IDXX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -7.07 | Sell |
| Relative Strength Index (14 RSI): | 50.94 | Buy |
| Chaikin Money Flow: | 741509 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (392.53 - 425.05) | Buy |
| Bollinger Bands (100): | (406.94 - 445.68) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -10.07 | Sell |
| Relative Strength Index (14 RSI): | 31.45 | Sell |
| Chaikin Money Flow: | -1452145 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.97 - 79.33) | Sell |
| Bollinger Bands (100): | (79.54 - 128.22) | Sell |
IDXX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 394.18 | Buy |
| 20-day SMA: | 405.99 | Buy |
| 50-day SMA: | 427.72 | Sell |
| 200-day SMA: | 450.09 | Sell |
| 8-day EMA: | 401.22 | Buy |
| 20-day EMA: | 405.57 | Buy |
| 50-day EMA: | 417.7 | Sell |
| 200-day EMA: | 446.12 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.88 | Buy |
| 20-day SMA: | 60.79 | Sell |
| 50-day SMA: | 86.36 | Sell |
| 200-day SMA: | 118.53 | Sell |
| 8-day EMA: | 54.47 | Sell |
| 20-day EMA: | 62.27 | Sell |
| 50-day EMA: | 80.32 | Sell |
| 200-day EMA: | 108.23 | Sell |
IDEXX Laboratories Earnings Growth & IDXX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.16 per share, an increase this year of $1.29 per share, and an increase next year of $1.51 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.98 per share, and an increase next year of $6.27 per share.
IDEXX Laboratories Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||